Ursodeoxycholic acid after bile duct stone removal and risk factors for recurrence: A randomized trial

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 23, Issue 2, 2016, Pages 132-136

  Yamamoto, Ryuichi ^a   Tazuma, Susumu ^a   Kanno, Keishi ^a   Igarashi, Yoshinori ^b   Inui, Kazuo ^c   Ohara, Hirotaka ^d   Tsuyuguchi, Toshio ^e   Ryozawa, Shomei ^f  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

Common bile duct stones; Randomized controlled trial; Recurrence; Ursodeoxycholic acid

Indexed keywords

URSODEOXYCHOLIC ACID;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BILE DUCT STONE; BILE DUCT STONE REMOVAL; BLOOD EXAMINATION; BODY MASS; BRADYCARDIA; CHOLECYSTECTOMY; CHOLECYSTITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DYSLIPIDEMIA; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; GALLSTONE; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; LIFESTYLE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OPEN STUDY; POSTOPERATIVE HEMORRHAGE; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; TREATMENT DURATION; VERY ELDERLY; YOUNG ADULT; CLINICAL TRIAL; GALLSTONES; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; CHOLECYSTECTOMY; FEMALE; GALLSTONES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RISK FACTORS; URSODEOXYCHOLIC ACID;

EID: 84957717625     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.316     Document Type: Article

References (15)

1. Kawai K, Akasaka Y, Murakami K, Tada M, Koli Y,. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc. 1974; 20: 148-51.
2. Staritz M, Ewe K, Meyer zum Büschenfelde KH,. Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and papillary stenosis. Endoscopy. 1983; 15: 197-8.
3. Yasuda I, Doi S, Iwashita T, Oonishi T, Mukai T, Shioya M, et al., Recurrence of common bile duct stones after endoscopic procedures in relation to papillary function. Tan to Sui (J Biliary Tract Pancreas). 2007; 28: 15-9.
4. Salvioli G, Salati R, Lugli R, Zanni C,. Medical treatment of biliary duct stones: effect of ursodeoxycholic acid administration. Gut. 1983; 24: 609-14.
5. Swobodnik W, Janowitz P, Kratzer W, Wenk H, Neuhaus H, Malfertheiner P, et al., Preventing the recurrence of common bile duct calculi following endoscopic papillotomy with ursodeoxycholic acid. Z Gastroenterol. 1990; 28: 621-5.
6. Maki T,. Pathogenesis of calcium bilirubinate gallstone: role of E. coli, beta-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg. 1966; 164: 90-100.
7. Ohya T, Murakami E, Kougame A, Numata Y, Hiraoka M,. Proposal of endoscopic lithotripsy for common bile duct stones based on pathogenesis of stone formation. Tando. 2008; 22: 617-23.
8. Cheon YK, Lehman GA,. Identification of risk factors for stone recurrence after endoscopic treatment of bile duct stones. Eur J Gastroenterol Hepatol. 2006; 18: 461-4.
9. Osanai M, Maguchi H, Takahashi K,. Treatment outcomes and complications of EST and EPBD for bile duct stones. Gastroenterology. 2006; 43: 539-43.
10. Hashimoto A, Moritani I, Shimizu A, Oyama M, Kobayashi K,. Short-term and long-term prognosis of EPBD and EST for common bile duct stones. Gastroenterology. 2005; 41: 83-9.
11. Yasuda I, Fujita N, Maguchi H, Komatsu Y, Hasebe O, Igarashi Y, et al., Short-term and long-term outcomes of endoscopic procedures (EST and EPBD) for bile duct stones: Results of the JESED study. Tan to Sui (J Biliary Tract Pancreas). 2010; 3: 259-61.
12. Kikuchi H, Kida M, Saigenji K,. Long-term prognosis after EST or EPBD in endoscopic procedures for common bile duct stones. Gastroenterology. 2005; 41: 90-4.
13. Akashi R, Kiyozumi T, Kanda K, Nakahara K, Hanaka C,. Study of single recurrence and cumulative recurrence of bile duct stones after endoscopic sphincterotomy (EST). Tan to Sui (J Biliary Tract Pancreas). 2010; 31: 239-45.
14. Tsujino T, Isayama H, Ito Y, Mizuno T, Yamamoto K, Yajima Y, et al., Long-term outcomes of treatment of bile duct stones with endoscopic papillary balloon dilation (EPBD). Tan to Sui (J Biliary Tract Pancreas). 2010; 31: 251-7.
15. Lai KH, Peng NJ, Lo GH, Cheng JS, Huang RL, Lin CK, et al., Prediction of recurrent choledocholithiasis by quantitative cholescintigraphy in patients after endoscopic sphincterotomy. Gut. 1997; 41: 399-403.